Navigation Links
Improvements in embryonic preimplantation genetic screening techniques
Date:4/13/2011

A Short Comparative Genomic Hybridisation (CGH) method has been developed to carry out preimplantation genetic screening (PGS) by analysing all chromosomes and transferring selected embryos to the recipient uterus in the same in vitro fertilisation cycle. This eliminates the need to freeze them.

The technique has been applied to the screening of chromosomal anomalies in cases of advanced maternal age, recurrent miscarriages or repeated implantation failures.

Short-CGH achieved, as part of a PGS programme, the pregnancy of a woman whose partner is carrier of two chromosomal translocations, a very rare case which commonly causes infertility, miscarriages or physical and/or mental malformations in the newborn.

The technique developed is the result of a doctoral thesis by Mariona Rius, member of the research team belonging to the Cell Biology and Medical Genetics Unit of the Department of Cell Biology, Physiology and Immunology at Universitat Autnoma de Barcelona (UAB). The project received funding from the Spanish Health Research Fund and was carried out under the Eugin Research Chair - UAB.

Preimplantation Genetic Screening (PGS), through in vitro fertilisation (IVF) treatment, allows selecting healthy embryos with no anomalies which are later transferred to the recipient uterus, thus increasing chances of implantation.

Presently, the methodology most frequently used is the analysis of one cell of the embryo the third day of its development through fluorescent in situ hybridisation (FISH), which routinely analyses only nine of the 24 different types of existing chromosomes. The selected embryos are transferred to the recipient uterus four days after beginning, in the same IVF cycle. The implantation rate using this technique is 14%.

An alternative technique, used in few centres in the world, is Comparative Genomic Hybridisation (CGH) which allows for a comprehensive cytogenetic analysis of all chromosomes to check for anomalies of full chromosomes (aneuploidy) or only of parts. This methodology, however, is highly complex and needs more time than the IVF cycle to yield results (72 hours). Therefore, the embryos analysed must be cryopreserved and transferred in a subsequent IVF cycle, which could affect their viability. The implantation rate using this technique ranges from 40 to 70 %.

In her doctoral thesis, Mariona Rius developed a short-CGH method which allows the full karyotype study of the cell (blastomere) with a very reduced hybridisation period (from 72 to 12 hours). Using only one procedure and with the same efficacy, short-CGH permits scientists to detect not only aberrations in the number of chromosomes (numerical), but also alterations in chromosome fragments (structural). Thus the embryos selected chromosomally normal can be transferred within the same IVF cycle.

The technique was applied clinically in the screening of chromosomal abnormalities in cases of advanced maternal age, recurrent miscarriages or repeated implantation failures. The implantation rate of transferred embryos reached 60%. It was also used, for the first time in a PGS programme, to obtain a successful pregnancy of a woman whose partner is carrier of two chromosomal translocations, one reciprocal and the other Robertsonian. This is a very rare case which frequently causes infertility, miscarriages or physical and/or mental malformations in the newborn. Of the 16 embryos analysed in three consecutive IVF cycles, the only embryo without chromosomal imbalances was transferred to the woman, who is currently in the third trimester of her pregnancy.

Given the results obtained in this first research phase, researchers are confident that the short-CGH method will be applied in more PGS tests.


'/>"/>

Contact: Maria Jesus Delgado
MariaJesus.Delgado@uab.cat
34-935-814-049
Universitat Autonoma de Barcelona
Source:Eurekalert

Related biology news :

1. Microreactors: Small scale chemistry could lead to big improvements for biodegradable polymers
2. Key nutrient in maternal diet promises dramatic improvements for people with Down syndrome
3. Womens support groups make dramatic improvements on neonatal survival rates
4. Repulsion more important than cohesion in embryonic tissue separation
5. States now fund majority of human embryonic stem cell research
6. Research!America asks Congress to support embryonic stem cell research now
7. Congressman, CSHL president urge quick action to reverse judicial embryonic stem cell research ban
8. Ronin recruits protein allies to sustain embryonic stem cell growth
9. New culture dish could advance human embryonic stem cell research
10. UCI researchers create retina from human embryonic stem cells
11. Study finds protein that plays key role in early embryonic development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2016)... Jan. 22, 2016 ... of the "Global Biometrics Market in ... offering. --> http://www.researchandmarkets.com/research/p74whf/global_biometrics ) ... "Global Biometrics Market in Retail Sector 2016-2020" ... --> Research and Markets ( http://www.researchandmarkets.com/research/p74whf/global_biometrics ...
(Date:1/20/2016)... A market that just keeps on growing. ... explosion in genomics knowledge. Learn all about it in ... of dynamic trends are pushing market growth and company ... pharmacogenomics - pathogen evolution - next generation sequencing - ... understanding of the role of genetic material in Disease ...
(Date:1/20/2016)... Calif. , Jan. 20, 2016  Synaptics ... of human interface solutions, today announced sampling of ... solution for wearables and small screen applications including ... as printers. Supporting round and rectangular shapes, as ... offers excellent performance with moisture on screen, while ...
Breaking Biology News(10 mins):
(Date:2/5/2016)... , Feb. 5, 2016  In the pharmaceutical ... for a host of launch activities including the identification ... this launch activity is especially high in the oncology ... Best Practices and the Role of Medical Affairs ... companies focused on oncology therapies find better ways to ...
(Date:2/5/2016)... , February 5, 2016 Amarantus ... biotechnology company focused on developing products for Regenerative Medicine, ... Rare Pediatric Disease Designation (RPDD) from the US Food ... with MANF. MANF was previously granted orphan drug designation ... --> Amarantus BioScience Holdings, Inc. (OTCQB: ...
(Date:2/4/2016)... ... February 04, 2016 , ... Morf Media Inc ... an interactive FDA compliance training course, Writing Effective SOPs ... accredited interactive course on Morf Playbook—now conveniently available on smartphones and PCs--provides step ...
(Date:2/4/2016)... 2016  Sangamo BioSciences, Inc. (NASDAQ: SGMO ), ... Edward Lanphier , Sangamo,s president and chief executive ... Sangamo,s ZFP Therapeutic ® development programs and an ... ET on Thursday, February 11, 2016, at the Leerink ... conference is being held in New York ...
Breaking Biology Technology: